- Home
- GDEN vs XNCR Comparison
GDEN vs XNCR Comparison
Compare GDEN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEN | XNCR |
|---|---|---|
| Founded | N/A | 1997 |
| Country | United States | United States |
| Employees | 504 | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 763.2M | 881.9M |
| IPO Year | 1998 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GDEN | XNCR |
|---|---|---|
| Price | $28.59 | $11.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $32.25 | $22.33 |
| AVG Volume (30 Days) | ★ 2.4M | 608.9K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.50% | N/A |
| EPS Growth | N/A | ★ 65.36 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $634,911,000.00 | $125,576,000.00 |
| Revenue This Year | $5.17 | N/A |
| Revenue Next Year | $2.87 | $4.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 13.65 |
| 52 Week Low | $19.57 | $6.92 |
| 52 Week High | $32.74 | $18.69 |
Technical Indicators
Market Signals| Indicator | GDEN | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 61.46 | 43.74 |
| Support Level | $28.30 | $10.83 |
| Resistance Level | $28.78 | $12.65 |
| Average True Range (ATR) | 0.37 | 0.55 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 74.93 | 46.61 |
Price Performance
Historical ComparisonAbout GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.